Yinang formulation versus placebo granules as a treatment for chronic kidney disease stages III–IV in patients with autosomal dominant polycystic kidney disease: study protocol for a double-blind placebo-controlled randomized clinical trial

BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common potentially life-threatening inherited kidney diseases. It is the fourth most common cause of end-stage renal disease requiring renal replacement therapy. There are few management options for controlling disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Jing, Wu, Yansheng, Gong, Xuezhong, Ma, Yiyi, Yu, Shengqiang, Gao, Jiandong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686499/
https://www.ncbi.nlm.nih.gov/pubmed/31391092
http://dx.doi.org/10.1186/s13063-019-3563-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686499/
https://www.ncbi.nlm.nih.gov/pubmed/31391092
http://dx.doi.org/10.1186/s13063-019-3563-5

Ejemplares similares